Zobrazeno 1 - 10
of 257
pro vyhledávání: '"George J Weiner"'
Autor:
Xuefeng Wang, Igor Puzanov, Abdul Rafeh Naqash, Ahmad A Tarhini, George J Weiner, Phaedra Agius, Margaret E Gatti-Mays, Howard Colman, Aik Choon Tan, Issam El Naqa, Timothy I Shaw, Aakrosh Ratan, Martin D McCarter, John Carpten, Susanne M Arnold, Michelle Churchman, Michael D Radmacher, Oliver A Hampton, David M McKean, Daniel R Elgort, Robert J Rounbehler, Donghai Dai, Tingyi Li, William S Dalton
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/801cbc91062449379d40afd58c6cfbc8
Autor:
Xuefeng Wang, Patrick Hwu, Igor Puzanov, Abdul Rafeh Naqash, Ahmad A Tarhini, George J Weiner, Margaret E Gatti-Mays, Howard Colman, Timothy I Shaw, Aakrosh Ratan, Martin D McCarter, John Carpten, Susanne M Arnold, Michelle Churchman, Tingyi Li, William S Dalton, Sijie Yao, Islam Eljilany
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/321fb93ef7f6459ba00fd4750df6279a
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/e11e830f330348c79d5df6ebc16ef1db
Autor:
George J Weiner, Caitlin D Lemke-Miltner, Andrean L Simons, MM Hasibuzzaman, Briana Ibarra, Ishrat Khan
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/9bb055443b834cd8af2c0910fb582951
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/67865b221600485da1a80772cfc37edc
Autor:
Xuefeng Wang, Igor Puzanov, Abdul Rafeh Naqash, Paulo C Rodriguez, George J Weiner, Jose Conejo-Garcia, Jamie Teer, Xiaoqing Yu, Margaret E Gatti-Mays, William Dalton, Howard Colman, Aik Choon Tan, Timothy I Shaw, Darwin Chang, Alyssa Obermayer, Dale Hedges, Aakrosh Ratan, Martin D McCarter, John Carpten, Susanne M Arnold, Michelle Churchman
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/0258ce1216ab4d38926536bfebfd3189
Autor:
George J Weiner, Aliasger K Salem, Shakoora A Sabree, Andrew P Voigt, Sue E Blackwell, Ajaykumar Vishwakarma, Michael S Chimenti
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 6 (2021)
Background CMP-001, also known as vidutolimod, is a virus-like particle containing a TLR9 agonist that is showing promise in early clinical trials. Our group previously demonstrated that the immunostimulatory effects of CMP-001 are dependent on an an
Externí odkaz:
https://doaj.org/article/4b2849718b58408bbeccee7f317793da
Publikováno v:
Journal of Hematology & Oncology, Vol 14, Iss 1, Pp 1-4 (2021)
Abstract Resistance to anti-cancer monoclonal antibody (mAb) therapy remains a clinical challenge. Previous work in our laboratory has shown that T cell help in the form of interleukin-2 maintains long-term NK cell viability and NK cell-mediated anti
Externí odkaz:
https://doaj.org/article/5a38ad7f8b4448029326cedc3eabfd19
Autor:
Yinwen Cheng, Nicholas Borcherding, Ayomide Ogunsakin, Caitlin D. Lemke-Miltner, Katherine N. Gibson-Corley, Anand Rajan, Allen B. Choi, Wattawan Wongpattaraworakul, Carlos H. F. Chan, Aliasger K. Salem, George J. Weiner, Andrean L. Simons
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-11 (2021)
Abstract The Toll-like receptor 8 (TLR8) agonist VTX-2337 (motolimod) is an anti-cancer immunotherapeutic agent that is believed to augment natural killer (NK) and dendritic cell (DC) activity. The goal of this work is to examine the role of TLR8 exp
Externí odkaz:
https://doaj.org/article/d67bc1582e584855affb057717db487d
Autor:
Shakoora A. Sabree, Caitlin D. Lemke-Miltner, Sue E. Blackwell, Chaobo Yin, Aaron Bossler, Kareem Ebeid, Aliasger K. Salem, George J. Weiner
Publikováno v:
Vaccines, Vol 9, Iss 9, p 982 (2021)
Vidutolimod, also known as CMP-001, is a virus-like particle composed of the Qβ bacteriophage coat protein encasing a TLR9 agonist. Vidutolimod injected intratumorally is showing promise in early phase clinical trials based on its ability to alter t
Externí odkaz:
https://doaj.org/article/166b965f36da434991cb4fa3e3371783